Fundraising FoxAvista — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
OmniAb develops transgenic animal platforms engineered to generate human antibodies for therapeutic drug discovery, serving biopharmaceutical researchers and drug developers.
AI & Machine LearningBiotechDeep TechEmeryville, US
Kurt Gustafson(Chief Financial Officer)inCharles Berkman(Chief Legal Officer)inMatt Foehr(Chief Executive Officer)inAmechi Nwachuku(Chief Operating Officer)inKurt A. Gustafson(Executive Vice President, Finance and Chief Financial Officer)inCharles S. Berkman(Chief Legal Officer and Secretary)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.